|
WO2021081327A1
|
|
Biosynthesis of mogrosides
|
|
WO2021061910A1
|
|
Production of oligosaccharides
|
|
WO2021034848A1
|
|
Biosynthesis of cannabinoids and cannabinoid precursors
|
|
WO2020257702A1
|
|
Rare earth element (ree)-binding proteins
|
|
WO2020257707A1
|
|
Biosynthesis of enzymes for use in treatment of maple syrup urine disease (msud)
|
|
WO2020176547A1
|
|
Biosynthesis of cannabinoids and cannabinoid precursors
|
|
WO2020097588A1
|
|
Biosynthesis of mogrosides
|
|
KR20200121331A
|
|
Chimeric terpene synthase
|
|
WO2019055541A1
|
|
Protective enzymes
|
|
WO2019018759A1
|
|
Systems and methods for controlled fluid handling
|
|
EP3532633A2
|
|
Compositions and methods for the production of compounds
|
|
KR20190099397A
|
|
Compositions and Methods for the Production of Compounds
|
|
US2019194732A1
|
|
Device and method for nucleic acid manipulation
|
|
US2017074889A1
|
|
Methods and systems for cell state quantification
|
|
AU2015236045A1
|
|
Methods and genetic systems for cell engineering
|
|
AU2015218647A1
|
|
Diacylglycerol acyl transferase (DGA1) polynucleotides, and methods of increasing yeast cell lipid production by overexpression of heterologous DGA1
|
|
US2015315599A1
|
|
Methods and Systems for Methylotrophic Production of Organic Compounds
|
|
US2012064622A1
|
|
Methods and systems for chemoautotrophic production of organic compounds
|
